KRAS <sup>G12C</sup> inhibition produces a driver-limited state revealing collateral dependenciesKevin Lou, Luke A. Gilbert, Veronica Steri et al.|Science Signaling|2019Cited by 179
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K. Saha, Nabeel Bardeesy, John D. Gordan et al.|Cancer Discovery|2016Cited by 163
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancerHayley Donnella, Sourav Bandyopadhyay, James T. Webber et al.|Nature Chemical Biology|2018Cited by 92
Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem CellsGarry L. Coles, Julien Sage, Sandra Cristea et al.|Cancer Cell|2020Cited by 86
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with DasatinibRowan Miller, Alan Ashworth, Rachel Brough et al.|Molecular Cancer Therapeutics|2016Cited by 85